End-of-day quote
Taipei Exchange
18:00:00 2024-04-28 EDT
|
5-day change
|
1st Jan Change
|
91
TWD
|
0.00%
|
|
+1.00%
|
+5.32%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,905
|
5,082
|
5,452
|
5,481
|
6,273
|
6,607
|
-
|
Enterprise Value (EV)
1 |
4,905
|
4,865
|
4,867
|
4,793
|
6,273
|
5,764
|
5,608
|
P/E ratio
|
10.7
x
|
15.6
x
|
14.2
x
|
16.6
x
|
14.9
x
|
16
x
|
15
x
|
Yield
|
-
|
6%
|
5.99%
|
5.56%
|
-
|
5.6%
|
5.99%
|
Capitalization / Revenue
|
2.4
x
|
2.34
x
|
2.7
x
|
2.51
x
|
2.7
x
|
2.81
x
|
2.66
x
|
EV / Revenue
|
2.4
x
|
2.24
x
|
2.41
x
|
2.19
x
|
2.7
x
|
2.45
x
|
2.26
x
|
EV / EBITDA
|
-
|
7.96
x
|
10.3
x
|
9.53
x
|
9.79
x
|
9.25
x
|
8.52
x
|
EV / FCF
|
19.3
x
|
9.66
x
|
16.9
x
|
12
x
|
-
|
11.3
x
|
10.7
x
|
FCF Yield
|
5.18%
|
10.4%
|
5.92%
|
8.37%
|
-
|
8.83%
|
9.38%
|
Price to Book
|
1.92
x
|
1.94
x
|
2.02
x
|
2.02
x
|
-
|
2.28
x
|
2.23
x
|
Nbr of stocks (in thousands)
|
72,600
|
72,600
|
72,600
|
72,600
|
72,600
|
72,600
|
-
|
Reference price
2 |
67.56
|
70.00
|
75.10
|
75.50
|
86.40
|
91.00
|
91.00
|
Announcement Date
|
20-02-26
|
21-02-25
|
22-02-25
|
23-02-24
|
24-03-01
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,041
|
2,172
|
2,019
|
2,185
|
2,320
|
2,354
|
2,480
|
EBITDA
1 |
-
|
610.9
|
473.9
|
502.9
|
640.9
|
623
|
658
|
EBIT
1 |
347.3
|
440.9
|
313.4
|
354.5
|
498
|
481
|
517
|
Operating Margin
|
17.02%
|
20.3%
|
15.52%
|
16.22%
|
21.46%
|
20.43%
|
20.85%
|
Earnings before Tax (EBT)
1 |
529.8
|
422.7
|
434
|
413.5
|
525.5
|
515
|
550
|
Net income
1 |
459.1
|
328.7
|
386.4
|
331.4
|
420.8
|
412
|
440
|
Net margin
|
22.5%
|
15.14%
|
19.14%
|
15.17%
|
18.14%
|
17.5%
|
17.74%
|
EPS
2 |
6.292
|
4.500
|
5.290
|
4.540
|
5.800
|
5.670
|
6.060
|
Free Cash Flow
1 |
253.8
|
503.8
|
288.3
|
401
|
-
|
509
|
526
|
FCF margin
|
12.44%
|
23.19%
|
14.28%
|
18.35%
|
-
|
21.62%
|
21.21%
|
FCF Conversion (EBITDA)
|
-
|
82.47%
|
60.85%
|
79.73%
|
-
|
81.7%
|
79.94%
|
FCF Conversion (Net income)
|
55.29%
|
153.25%
|
74.62%
|
120.99%
|
-
|
123.54%
|
119.55%
|
Dividend per Share
2 |
-
|
4.200
|
4.500
|
4.200
|
-
|
5.100
|
5.450
|
Announcement Date
|
20-02-26
|
21-02-25
|
22-02-25
|
23-02-24
|
24-03-01
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
465.8
|
485.7
|
495.5
|
488.7
|
583.2
|
617.6
|
626.3
|
593.4
|
580.7
|
519.8
|
578
|
584
|
587
|
604
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
66.83
|
55.23
|
55.56
|
66.06
|
110.9
|
121.9
|
139
|
126.8
|
124.6
|
107.7
|
117
|
119
|
120
|
126
|
Operating Margin
|
14.35%
|
11.37%
|
11.21%
|
13.52%
|
19.02%
|
19.75%
|
22.19%
|
21.36%
|
21.46%
|
20.72%
|
20.24%
|
20.38%
|
20.44%
|
20.86%
|
Earnings before Tax (EBT)
1 |
215.7
|
50.3
|
70.21
|
73.92
|
141.2
|
128.1
|
142.4
|
137.1
|
154.8
|
91.15
|
125
|
127
|
128
|
134
|
Net income
1 |
205.7
|
40.46
|
55.96
|
58.81
|
112.9
|
103.7
|
113.6
|
110.5
|
123.8
|
72.91
|
100
|
102
|
103
|
107
|
Net margin
|
44.15%
|
8.33%
|
11.29%
|
12.03%
|
19.37%
|
16.79%
|
18.13%
|
18.62%
|
21.32%
|
14.03%
|
17.3%
|
17.47%
|
17.55%
|
17.72%
|
EPS
2 |
2.820
|
0.5400
|
0.7700
|
0.8100
|
1.550
|
1.420
|
1.560
|
1.520
|
1.700
|
1.010
|
1.380
|
1.400
|
1.410
|
1.480
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-04
|
22-02-25
|
22-05-06
|
22-08-05
|
22-11-10
|
23-02-24
|
23-05-09
|
23-08-09
|
23-11-09
|
24-03-01
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
217
|
585
|
688
|
-
|
843
|
999
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
254
|
504
|
288
|
401
|
-
|
509
|
526
|
ROE (net income / shareholders' equity)
|
18.9%
|
12.7%
|
14.5%
|
12.2%
|
-
|
14.2%
|
14.8%
|
ROA (Net income/ Total Assets)
|
12.2%
|
8.32%
|
9.98%
|
8.91%
|
-
|
11%
|
11.5%
|
Assets
1 |
3,768
|
3,949
|
3,872
|
3,721
|
-
|
3,745
|
3,826
|
Book Value Per Share
2 |
35.10
|
36.00
|
37.30
|
37.40
|
-
|
39.90
|
40.90
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
207
|
66.6
|
30.8
|
30.7
|
-
|
27
|
27
|
Capex / Sales
|
10.17%
|
3.07%
|
1.52%
|
1.41%
|
-
|
1.15%
|
1.09%
|
Announcement Date
|
20-02-26
|
21-02-25
|
22-02-25
|
23-02-24
|
24-03-01
|
-
|
-
|
Average target price
96
TWD Spread / Average Target +5.49% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.32% | 203M | | +11.63% | 27.84B | | -30.22% | 3.04B | | -14.68% | 2.56B | | +11.64% | 2.33B | | +2.96% | 1.99B | | -11.65% | 1.87B | | -1.67% | 1.49B | | +2.19% | 1.27B | | +3.29% | 1.12B |
Medical Supplies
|